| HAL-Inria | Publications, software ... of Inria's scientists |
Journal articles
Combinatorial immunotherapy strategies: most gods throw dice, but fate
Abstract : Immuno-oncology drugs (IODs) are considered as game-changing treatments in oncology, because diseases with once dismal prognosis such as metastatic melanoma or lung cancer now show 3-year survival rates in the 20-40% range. However, it has to be kept in mind
https://hal.inria.fr/hal-03147132
Contributor : Sebastien Benzekry Connect in order to contact the contributor
Submitted on : Friday, February 19, 2021 - 3:49:51 PM
Last modification on : Saturday, December 4, 2021 - 3:44:01 AM
Long-term archiving on: : Thursday, May 20, 2021 - 7:47:53 PM
Contributor : Sebastien Benzekry Connect in order to contact the contributor
Submitted on : Friday, February 19, 2021 - 3:49:51 PM
Last modification on : Saturday, December 4, 2021 - 3:44:01 AM
Long-term archiving on: : Thursday, May 20, 2021 - 7:47:53 PM
File
published_online_first.pdf
Files produced by the author(s)